Literature DB >> 7129661

Subthreshold and suboptimal desensitization of human basophils. II. Nonspecificity and irreversibility of desensitization.

G R Mendoza, K Minagawa.   

Abstract

Desensitization in human basophils was induced by suboptimal levels of antihuman IgE or antigen under normal calcium buffer conditions. Low doses of anti-IgE triggered only 0-12% histamine release during a 3-hour preincubation, yet initiated up to 100% desensitization upon rechallenge. After 24-27 h preincubation with allergen a, the cells did not regain releasability when rechallenged with either allergen a, allergen b or anti-IgE. Low dose, IgE-mediated desensitization in human basophils may lead to an irreversible and nonspecific inhibition of degranulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7129661     DOI: 10.1159/000233185

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  4 in total

1.  Findings of in vitro Analyses of Basophil Functions May Help Us Better Understand Drug Desensitization.

Authors:  Masao Yamaguchi; Akiko Komiya; Maho Suzukawa; Rikiya Koketsu; Risa Shiragami; Motoyasu Iikura; Hiroyuki Nagase
Journal:  Front Allergy       Date:  2022-03-30

2.  Induction of an auto-anti-IgE response in rats. IV. Effects on mast cell degranulation.

Authors:  G Jaffery; E B Bell; J W Coleman
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

3.  Timescale Separation of Positive and Negative Signaling Creates History-Dependent Responses to IgE Receptor Stimulation.

Authors:  Brooke Harmon; Lily A Chylek; Yanli Liu; Eshan D Mitra; Avanika Mahajan; Edwin A Saada; Benjamin R Schudel; David A Holowka; Barbara A Baird; Bridget S Wilson; William S Hlavacek; Anup K Singh
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

4.  Changes in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel.

Authors:  Mohamed Z Satti; Pierre Cahen; Per S Skov; Sarah Joseph; Frances M Jones; Colin Fitzsimmons; Karl F Hoffmann; Claus Reimert; H Curtis Kariuki; Francis Kazibwe; Joseph K Mwatha; Gachuhi Kimani; Birgitte J Vennervald; John H Ouma; Narcis B Kabatereine; David W Dunne
Journal:  BMC Immunol       Date:  2004-04-21       Impact factor: 3.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.